Cell biology: Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7

Science Signaling

Volumn 5, Issue 210, 2012, Pages

  Taylor, Kathryn M ^a   Hiscox, Stephen ^a   Nicholson, Robert I ^a   Hogstrand, Christer ^b   Kille, Peter ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; CATION CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE B; UNCLASSIFIED DRUG; ZINC; ZINC CHANNEL ZIP7;

ARTICLE; ASSAY; CONTROLLED STUDY; CYTOSOL; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 84856998257     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2002585     Document Type: Article

References (57)

1. B. L. Vallee, K. H. Falchuk, The biochemical basis of zinc physiology. Physiol. Rev. 73, 79-118 (1993).
2. A. S. Prasad, Impact of the discovery of human zinc deficiency on health. J. Am. Coll. Nutr. 28, 257-265 (2009).
3. S. L. Sensi, P. Paoletti, A. I. Bush, I. Sekler, Zinc in the physiology and pathology of the CNS. Nat. Rev. Neurosci. 10, 780-791 (2009).
4. H. Haase, L. Rink, The immune system and the impact of zinc during aging. Immun. Ageing 6, 9 (2009).
5. R. Sladek, G. Rocheleau, J. Rung, C. Dina, L. Shen, D. Serre, P. Boutin, D. Vincent, A. Belisle, S. Hadjadj, B. Balkau, B. Heude, G. Charpentier, T. J. Hudson, A. Montpetit, A. V. Pshezhetsky, M. Prentki, B. I. Posner, D. J. Balding, D. Meyre, C. Polychronakos, P. Froguel, A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885 (2007).
6. K. M. Taylor, P. Vichova, N. Jordan, S. Hiscox, R. Hendley, R. I. Nicholson, ZIP7- mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer cells. Endocrinology 149, 4912-4920 (2008).
7. L. Rink, Zinc in Human Health (IOS Press, Amsterdam, 2011).
8. S. Yamashita, C. Miyagi, T. Fukada, N. Kagara, Y. S. Che, T. Hirano, Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer. Nature 429, 298-302 (2004).
9. C. Hogstrand, P. Kille, R. I. Nicholson, K. M. Taylor, Zinc transporters and cancer: A potential role for ZIP7 as a hub for tyrosine kinase activation. Trends Mol. Med. 15, 101-111 (2009).
10. T. Fukada, T. Kambe, Molecular and genetic features of zinc transporters in physiology and pathogenesis. Metallomics 3, 662-674 (2011).
11. A. Passerini, C. Andreini, S. Menchetti, A. Rosato, P. Frasconi, Predicting zinc binding at the proteome level. BMC Bioinformatics 8, 39 (2007).
12. J. H. Laity, G. K. Andrews, Understanding the mechanisms of zinc-sensing by metalresponse element binding transcription factor-1 (MTF-1). Arch. Biochem. Biophys. 463, 201-210 (2007).
13. C. Hogstrand, D. Zheng, G. Feeney, P. Cunningham, P. Kille, Zinc-controlled gene expression by metal-regulatory transcription factor 1 (MTF1) in a model vertebrate, the zebrafish. Biochem. Soc. Trans. 36, 1252-1257 (2008).
14. S. Yamasaki, K. Sakata-Sogawa, A. Hasegawa, T. Suzuki, K. Kabu, E. Sato, T. Kurosaki, S. Yamashita, M. Tokunaga, K. Nishida, T. Hirano, Zinc is a novel intracellular second messenger. J. Cell Biol. 177, 637-645 (2007).
15. H. Haase, W. Maret, Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals 18, 333-338 (2005).
16. W. Maret, Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc. Exp. Gerontol. 43, 363-369 (2008).
17. R. A. Colvin, W. R. Holmes, C. P. Fontaine, W. Maret, Cytosolic zinc buffering and muffling: Their role in intracellular zinc homeostasis. Metallomics 2, 306-317 (2010).
18. I. Sekler, S. L. Sensi, M. Hershfinkel, W. F. Silverman, Mechanism and regulation of cellular zinc transport. Mol. Med. 13, 337-343 (2007).
19. K. M. Taylor, R. I. Nicholson, The LZT proteins; the LIV-1 subfamily of zinc transporters. Biochim. Biophys. Acta 1611, 16-30 (2003).
20. W. Lin, J. Chai, J. Love, D. Fu, Selective electrodiffusion of zinc ions in a Zrt-, Irt-like protein, ZIPB. J. Biol. Chem. 285, 39013-39020 (2010).
21. K. M. Taylor, H. E. Morgan, A. Johnson, R. I. Nicholson, Structure-function analysis of HKE4, a member of the new LIV-1 subfamily of zinc transporters. Biochem. J. 377, 131-139 (2004).
22. L. Huang, C. P. Kirschke, Y. Zhang, Y. Y. Yu, The ZIP7 gene (Slc39a7) encodes a zinc transporter involved in zinc homeostasis of the Golgi apparatus. J. Biol. Chem. 280, 15456-15463 (2005).
23. A. Suzuki, T. Endo, Ermelin, an endoplasmic reticulum transmembrane protein, contains the novel HELP domain conserved in eukaryotes. Gene 284, 31-40 (2002).
24. D. G. Stathakis, D. Y. Burton, W. E. McIvor, S. Krishnakumar, T. R.Wright, J. M.O'Donnell, The catecholamines up (Catsup) protein of Drosophila melanogaster functions as a negative regulator of tyrosine hydroxylase activity. Genetics 153, 361-382 (1999).
25. J. Lasswell, L. E. Rogg, D. C. Nelson, C. Rongey, B. Bartel, Cloning and characterization of IAR1, a gene required for auxin conjugate sensitivity in Arabidopsis. Plant Cell 12, 2395-2408 (2000).
26. K. M. Taylor, A distinct role in breast cancer for two LIV-1 family zinc transporters. Biochem. Soc. Trans. 36, 1247-1251 (2008).
27. K. A. Jackson, R. A. Valentine, L. J. Coneyworth, J. C. Mathers, D. Ford, Mechanisms of mammalian zinc-regulated gene expression. Biochem. Soc. Trans. 36, 1262-1266 (2008).
28. G. K. Andrews, Regulation and function of Zip4, the acrodermatitis enteropathica gene. Biochem. Soc. Trans. 36, 1242-1246 (2008).
29. K. M. Taylor, H. E. Morgan, K. Smart, N. M. Zahari, S. Pumford, I. O. Ellis, J. F. Robertson, R. I. Nicholson, The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer. Mol. Med. 13, 396-406 (2007).
30. S. Hiscox, L. Morgan, D. Barrow, C. Dutkowskil, A. Wakeling, R. I. Nicholson, Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib ('Iressa', ZD1839). Clin. Exp. Metastasis 21, 201-212 (2004).
31. J. M. Knowlden, I. R. Hutcheson, H. E. Jones, T. Madden, J. M. Gee, M. E. Harper, D. Barrow, A. E. Wakeling, R. I. Nicholson, Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. Endocrinology 144, 1032-1044 (2003).
32. J. M. Knowlden, I. R. Hutcheson, D. Barrow, J. M. Gee, R. I. Nicholson, Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: A supporting role to the epidermal growth factor receptor. Endocrinology 146, 4609-4618 (2005).
33. K. Niefind, J. Raaf, O. G. Issinger, Protein kinase CK2 in health and disease: Protein kinase CK2: From structures to insights. Cell. Mol. Life Sci. 66, 1800-1816 (2009).
34. N. A. St-Denis, D. W. Litchfield, Protein kinase CK2 in health and disease: From birth to death: The role of protein kinase CK2 in the regulation of cell proliferation and survival. Cell. Mol. Life Sci. 66, 1817-1829 (2009).
35. F. S. Oppermann, F. Gnad, J. V. Olsen, R. Hornberger, Z. Greff, G. Keri, M. Mann, H. Daub, Large-scale proteomics analysis of the human kinome. Mol. Cell. Proteomics 8, 1751-1764 (2009).
36. R. P. Zahedi,U. Lewandrowski, J.Wiesner, S.Wortelkamp, J.Moebius,C. Schütz, U. Walter, S. Gambaryan, A. Sickmann, Phosphoproteome of resting human platelets. J. Proteome Res. 7, 526-534 (2008).
37. J. E. Kim, S. R. Tannenbaum, F. M. White, Global phosphoproteome of HT-29 human colon adenocarcinoma cells. J. Proteome Res. 4, 1339-1346 (2005).
38. P. Puntervoll, R. Linding, C. Gemund, S. Chabanis-Davidson, M. Mattingsdal, S. Cameron, D. M. Martin, G. Ausiello, B. Brannetti, A. Costantini, F. Ferrè, V. Maselli, A. Via, G. Cesareni, F. Diella, G. Superti-Furga, L. Wyrwicz, C. Ramu, C. McGuigan, R. Gudavalli, I. Letunic, P. Bork, L. Rychlewski, B. Küster, M. Helmer-Citterich, W.N. Hunter, R. Aasland, T. J. Gibson, ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res. 31, 3625-3630 (2003).
39. L. A. Pinna, The raison d'etre of constitutively active protein kinases: The lesson of CK2. Acc. Chem. Res. 36, 378-384 (2003).
40. ++, and renal gluconeogenesis. Proc. Natl. Acad. Sci. U.S.A. 65, 368-374 (1970).
41. T. Fukada, S. Yamasaki, K. Nishida, M. Murakami, T. Hirano, Zinc homeostasis and signaling in health and diseases: Zinc signaling. J. Biol. Inorg. Chem. 16, 1123-1134 (2011).
42. B. P. Weaver, J. Dufner-Beattie, T. Kambe, G. K. Andrews, Novel zinc-responsive post-transcriptional mechanisms reciprocally regulate expression of the mouse Slc39a4 and Slc39a5 zinc transporters (Zip4 and Zip5). Biol. Chem. 388, 1301-1312 (2007).
43. D. M. Johnson, S. Yamaji, J. Tennant, S. K. Srai, P. A. Sharp, Regulation of divalent metal transporter expression in human intestinal epithelial cells following exposure to non-haem iron. FEBS Lett. 579, 1923-1929 (2005).
44. M. J. Petris, K. Smith, J. Lee, D. J. Thiele, Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. J. Biol. Chem. 278, 9639-9646 (2003).
45. P. V. van den Berghe, L. W. Klomp, Posttranslational regulation of copper transporters. J. Biol. Inorg. Chem. 15, 37-46 (2010).
46. 3 receptors channel calcium into cell death. Curr. Biol. 14, R933-R935 (2004).
47. J. S. Duncan, D. W. Litchfield, Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim. Biophys. Acta 1784, 33-47 (2008).
48. C. W. Yde, T. Frogne, A. E. Lykkesfeldt, I. Fichtner, O. G. Issinger, J. Stenvang, Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT. Cancer Lett. 256, 229-237 (2007).
49. A. M. Solares, A. Santana, I. Baladron, C. Valenzuela, C. A. González, A. Diaz, D. Castillo, T. Ramos, R. Gomez, D. F. Alonso, L. Herrera, H. Sigman, S. E. Perea, B. E. Acevedo, P. Lopez-Saura, Safety and preliminary efficacy data of a novel casein kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies. BMC Cancer 9, 146 (2009).
50. K. M. Taylor, J. M. W. Gee, P. Kille, Zinc and cancer, in Zinc in Human Health, L. Rink, Ed. (IOS Press, Amsterdam, 2011), pp. 283-304.
51. L. A. Pinna, J. E. Allende, Protein kinase CK2 in health and disease: Protein kinase CK2: An ugly duckling in the kinome pond. Cell. Mol. Life Sci. 66, 1795-1799 (2009).
52. L. Chantalat, D. Leroy, O. Filhol, A. Nueda, M. J. Benitez, E. M. Chambaz, C. Cochet, O. Dideberg, Crystal structure of the human protein kinase CK2 regulatory subunit reveals its zinc finger-mediated dimerization. EMBO J. 18, 2930-2940 (1999).
53. W. Maret, Metals on the move: Zinc ions in cellular regulation and in the coordination dynamics of zinc proteins. Biometals 24, 411-418 (2011).
54. A. Formigari, P. Irato, A. Santon, Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: Biochemical and cytochemical aspects. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 146, 443-459 (2007).
55. A. Q. Truong-Tran, L. H. Ho, F. Chai, P. D. Zalewski, Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. J. Nutr. 130, 1459S-1466S (2000).
56. A. M. Kim, S. Vogt, T. V. O'Halloran, T. K. Woodruff, Zinc availability regulates exit from meiosis in maturing mammalian oocytes. Nat. Chem. Biol. 6, 674-681 (2010).
57. G. E. Moore, R. E. Gerner, H. A. Franklin, Culture of normal human leukocytes. JAMA 199, 519-524 (1967).